Gut epithelial TSC1/mTOR controls RIPK3-dependent necroptosis in intestinal inflammation and cancer
Yadong Xie(First Hospital of Lanzhou University), Hui Xiao(Kunming University of Science and Technology), Jun Cui(Xinjiang Medical University), Dianhui Shao(Chinese Academy of Sciences), Yifan Zhao(Unknown), Shuzhong Cui(Guangzhou Medical University), Ken Cadwell(University of Pennsylvania), Xiaomin Yao(New York University), Zunfu Ke(Sun Yat-sen University), Wěi Li(Shougang (China)), Xiaoxia Li(Fujian Medical University), Yan Chen(Zhengzhou University), Tiantian Li(Harbin Medical University), Min Li(Sun Yat-sen University), Jian Li(Xinjiang Medical University), Xia Chen(Jinan University), Kun Chen(Central South University), Xiaoming Zhang(Jilin University), Lei Shi(Chongqing University), Yu Matsuzawa(New York University), Haiwei Zhang(Boston Children's Hospital), Qibin Leng(State Key Laboratory of Respiratory Disease), Haibing Zhang(Zhengzhou University), Hong Wei(Huazhong Agricultural University), Hua‐Bin Li(Liaocheng University)
Cited by 210
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
HIF-1α pathway: role, regulation and intervention for cancer therapy
|Acta Pharmaceutica Sinica B|2015|1.9k
Autophagy in major human diseases
|The EMBO Journal|2021|1.6k
Antioxidant Phytochemicals for the Prevention and Treatment of Chronic Diseases
|Molecules|2015|1.4k